Literature DB >> 18656715

Rhinitis symptoms and comorbidities in the United States: burden of rhinitis in America survey.

Jennifer Derebery1, Eli Meltzer, Robert A Nathan, Paul E Stang, Ulka B Campbell, Marlo Corrao, Richard Stanford.   

Abstract

OBJECTIVE: To assess the burden of nasal symptoms in the United States (U.S.) and the comorbid conditions associated with nasal symptoms. SUBJECTS AND METHODS: A self-administered screening questionnaire and follow-up survey was sent to targeted households from a representative sample of 15,000 households in the U.S. Subjects with comorbid asthma completed the Asthma Control Test (ACT).
RESULTS: Out of 7024 evaluable subjects who responded, 3831 subjects were classified as rhinitis "sufferers." Individuals with active rhinitis symptoms were 1.5 to 4.5 times more likely to suffer from comorbid conditions including asthma, conjunctivitis, otitis media, sinusitis, eczema, food and insect bite allergies, migraine, and depression. Almost half of all respondents with moderate or severe rhinitis symptoms and comorbid asthma had poorly controlled asthma as defined by an ACT score of < or =19.
CONCLUSIONS: A strong relationship exists between rhinitis symptoms and various comorbidities, including asthma, in the U.S. population. Poorly controlled rhinitis contributes to the public health burden of rhinitis and asthma.

Entities:  

Mesh:

Year:  2008        PMID: 18656715     DOI: 10.1016/j.otohns.2008.05.019

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  10 in total

Review 1.  Sleep and allergic disease: a summary of the literature and future directions for research.

Authors:  Daphne Koinis-Mitchell; Timothy Craig; Cynthia A Esteban; Robert B Klein
Journal:  J Allergy Clin Immunol       Date:  2012-08-03       Impact factor: 10.793

2.  Allergic rhinitis: relationships with anxiety and mood syndromes.

Authors:  Randy A Sansone; Lori A Sansone
Journal:  Innov Clin Neurosci       Date:  2011-07

Review 3.  Congestion and sleep impairment in allergic rhinitis.

Authors:  Timothy J Craig; Amir Sherkat; Sahar Safaee
Journal:  Curr Allergy Asthma Rep       Date:  2010-03       Impact factor: 4.806

4.  Hay fever in childhood, traits Neuroticism and Conscientiousness as independent predictors of the occurrence of hay fever in adulthood.

Authors:  Helen Cheng; Jessica Deighton; Miranda Wolpert; Benjamin P Chapman; Ekaterina N Kornilaki; Luke Treglown; Adrian Furnham
Journal:  J Health Psychol       Date:  2015-04-02

5.  Comparison of corticosteroid nasal sprays in relation to concomitant use and cost of other prescription medications to treat allergic rhinitis symptoms: retrospective cohort analysis of pharmacy claims data.

Authors:  Cindy Garris; Manan Shah; Anna D'Souza; Richard Stanford
Journal:  Clin Drug Investig       Date:  2009       Impact factor: 2.859

Review 6.  Comparative analysis of allergic rhinitis in children and adults.

Authors:  Adriana Izquierdo-Domínguez; Antonio L Valero; Joaquim Mullol
Journal:  Curr Allergy Asthma Rep       Date:  2013-04       Impact factor: 4.806

7.  Septal injection in comparison with inferior turbinates injection of botulinum toxin A in patients with allergic rhinitis.

Authors:  Sayed Mojtaba Abtahi; Sayed Mostafa Hashemi; Sayed Hamidreza Abtahi; Bagher Bastani
Journal:  J Res Med Sci       Date:  2013-05       Impact factor: 1.852

8.  Clinical associations between allergies and rapid eye movement sleep disturbances.

Authors:  Shelley R Berson; Jaclyn Klimczak; Elizabeth A Prezio; Shirley Hu; Manoj Abraham
Journal:  Int Forum Allergy Rhinol       Date:  2018-02-20       Impact factor: 3.858

Review 9.  The Effectiveness of the Bacteria Derived Extremolyte Ectoine for the Treatment of Allergic Rhinitis.

Authors:  Andreas Bilstein; Nina Werkhäuser; Anna Rybachuk; Ralph Mösges
Journal:  Biomed Res Int       Date:  2021-06-01       Impact factor: 3.411

Review 10.  Ectoine in the Treatment of Irritations and Inflammations of the Eye Surface.

Authors:  Andreas Bilstein; Anja Heinrich; Anna Rybachuk; Ralph Mösges
Journal:  Biomed Res Int       Date:  2021-02-09       Impact factor: 3.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.